In This Issue: Drug Topics July/August 2024

The Mediterranean diet is largely considered one of the healthiest diets.

Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.

Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk.

Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.

Results of a study at the Veterans Health Administration found that feedback and education led to better medication outcomes for patients.

Study results are especially important for women, who are more likely to experience heart failure with mildly reduced or preserved ejection fraction.